In many retrospective cohort studies, the specificity of rapidly progressive ILD in PM/DM patients was 86% and the sensitivity was 77%, and among patients with DM, PM, or PM/DM-related ILD, anti-MDA5-positive patients had the worst prognosis, with almost half of them dying within 6 months of diagnosis. Here, IFIH1 is linked to interstitial lung disease.